Related Experiment Videos

[Surgical treatment for active infective endocarditis]

S Fukunaga1, H Akashi, K Tayama

  • 1Second Department of Surgery, Kurume University School of Medicine, Japan.

Insights

Surgical treatment for active infective endocarditis involving valve replacement, especially with annular abscesses, showed a 5-year survival rate of 81%. Key principles include optimal timing, debridement, and complete defect closure.

Area of Science:

  • Cardiology
  • Cardiac Surgery
  • Infectious Diseases

Background:

  • Active infective endocarditis (IE) poses significant risks, often necessitating surgical intervention.
  • Valve dysfunction and complications like annular abscesses complicate management.

Purpose of the Study:

  • To evaluate the surgical outcomes and long-term survival in patients with active infective endocarditis.
  • To analyze the effectiveness of different reconstructive techniques for paravalvular involvement.

Main Methods:

  • Retrospective analysis of 33 patients with active IE undergoing valve replacement between 1975 and 1995.
  • Detailed review of valve pathology, surgical procedures, reconstructive techniques, and patient outcomes.

Main Results:

  • 18 aortic, 11 mitral, and 4 combined aortic/mitral valve IE cases were treated.
  • 14 patients had annular abscess or mycotic aneurysm; 5 (15.2%) experienced operative/hospital mortality.
  • Actuarial survival rates were 81% at 5 years and 61% at 10 years; paravalvular leakage occurred in 5 cases, primarily due to persistent infection.

Conclusions:

  • Optimal surgical timing, thorough debridement of infected tissue, and complete defect closure are crucial for managing active IE.
  • Specific reconstructive techniques are vital for addressing paravalvular involvement and ensuring long-term success.

Related Concept Videos